MAIT cell activation may play a role in fatal outcomes among severe COVID-19 cases

MAIT cell activation may play a role in fatal outcomes among severe COVID-19 cases
Project design and overall conclusions of the St George’s, University of London and University of Oxford collaboration on immune parameters of ICU COVID-19 and severe influenza. Credit: Nicholas Provine, Jonathan Youngs, and Paul Klenerman, CC-BY 4.0,

The mortality rate of COVID-19 patients requiring mechanical ventilation is 30-40%, however, the immunological factors associated with death in critically ill COVID-19 patients are poorly understood. A study published in PLOS Pathogens by Jonathan Youngs at St. George's University of London, United Kingdom and colleagues suggests an association between systemic inflammation responses and increased mortality of COVID-19 patients.

Antibodies and T play a critical role in protection from viral illness, however the exact role of T cell and antibody responses in SARS-CoV-2 infection is unclear. To better understand the immune abnormalities linked to critical illness and death in COVID-19 patients on ICU, researchers conducted a prospective observational investigating the association of T cell and antibody responses with fatal outcome in severe COVID-19. They analyzed serum samples from 41 mechanically ventilated COVID-19 patients, performing immunophenotyping of T cell responses and a range of experiments analyzing antibody responses. They then compared their findings to a parallel set of 18 mechanically ventilated influenza patients, as well as to 12 mild COVID-19 patients and 12 healthy controls.

The researchers found that fatal COVID-19 infections were correlated with poorly coordinated systemic immune responses and elevated mucosal associated invariant (MAIT) cell activation were the strongest predictor of a fatal outcome. However, the study was limited in that it only analyzed samples in a cross sectional manner and did not observe how immune responses changed over the course of the infection. Future studies are needed to explain in depth how mortality-associated immune characteristics may develop over time.

According to the authors, "Our study yields an enhanced understanding of the differential immunopathogenic processes driving critical COVID-19 and influenza, which can translate into improved immunotherapeutic approaches in patients with severe viral pneumonitis."

"In critically ill patients on ICU with COVID-19 and influenza, an unbiased analysis of the antiviral revealed activation of a specific immune subset -Mucosal-associated invariant T (MAIT) cells—as a strong immunological predictor of death," the authors add. "Survival in critical COVID-19 is associated with focused immune responses driven mainly by one cytokine—interferon alpha—in contrast to the very broad pro-inflammatory responses seen in those with fatal disease. This cytokine pattern linked to death versus survival separates critical COVID-19 from influenza."

Explore further

High viral load in lungs linked to COVID-19 mortality

More information: Youngs J, Provine NM, Lim N, Sharpe HR, Amini A, Chen Y-L, et al. (2021) Identification of immune correlates of fatal outcomes in critically ill COVID-19 patients. PLoS Pathog 17(9): e1009804.
Journal information: PLoS Pathogens

Citation: MAIT cell activation may play a role in fatal outcomes among severe COVID-19 cases (2021, September 16) retrieved 18 October 2021 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors